Blair William & CO Immuno Gen, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$12.46 - $29.95 $1.54 Million - $3.7 Million	-123,597 Reduced 48.6%	130,723 $3.88 Million
Q3 2023 Nov 09, 2023	SELL	$14.09 - $19.87 $23,741 - $33,480	-1,685 Reduced 0.66%	254,320 $4.04 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $1.21 Million - $6.49 Million	-323,590 Reduced 55.83%	256,005 $4.83 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $862,450 - $1.16 Million	235,000 Added 68.2%	579,595 $2.23 Million
Q4 2022 Feb 10, 2023	BUY	$4.55 - $6.31 $353,762 - $490,602	77,750 Added 29.14%	344,595 $1.71 Million
Q3 2022 Nov 09, 2022	BUY	$4.48 - $6.47 $1,792 - $2,588	400 Added 0.15%	266,845 $1.28 Million
Q2 2022 Aug 10, 2022	SELL	$3.15 - $5.76 $856,689 - $1.57 Million	-271,965 Reduced 50.51%	266,445 $1.2 Million
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $12,460 - $21,879	2,925 Added 0.55%	538,410 $2.56 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $94,453 - $149,137	19,885 Added 3.86%	535,485 $3.97 Million
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $3,468 - $4,553	691 Added 0.13%	515,600 $2.92 Million
Q2 2021 Aug 12, 2021	SELL	$5.79 - $8.6 $5,158 - $7,662	-891 Reduced 0.17%	514,909 $3.39 Million
Q1 2021 May 13, 2021	BUY	$6.5 - $10.53 $1.99 Million - $3.22 Million	305,400 Added 145.15%	515,800 $4.18 Million
Q4 2020 Feb 09, 2021	BUY	$3.7 - $7.66 $151,811 - $314,289	41,030 Added 24.23%	210,400 $1.36 Million
Q3 2020 Nov 06, 2020	BUY	$3.45 - $4.89 $3,795 - $5,379	1,100 Added 0.65%	169,370 $610,000
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $8,007 - $12,880	2,412 Added 1.45%	168,270 $774,000
Q1 2020 May 11, 2020	SELL	$2.12 - $6.8 $25,011 - $80,226	-11,798 Reduced 6.64%	165,858 $566,000
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $8,903 - $22,950	3,957 Added 2.28%	177,656 $907,000
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $15,762 - $24,069	7,100 Added 4.26%	173,699 $420,000
Q2 2019 Aug 13, 2019	BUY	$1.8 - $3.3 $165,045 - $302,583	91,692 Added 122.41%	166,599 $362,000
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $22,735 - $55,754	9,434 Added 14.41%	74,907 $419,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $257,963 - $635,088	65,473 New	65,473 $366,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account